Androgenic Alopecia as a Predictive Factor for Benign Prostatic Hyperplasia

January 2018 in “ Universidad Privada Antenor Orrego ”

Alegre Yataco, Paola Stephanie

androgenic alopecia benign prostatic hyperplasia BPH male pattern baldness prostatic volume arterial hypertension

TLDR Male pattern baldness may be an early sign of noncancerous prostate enlargement.

The study conducted five years ago aimed to determine if androgenic alopecia (male pattern baldness) could be a predictor of benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate gland. The retrospective case-control study involved 128 patients, split evenly into two groups. The average age was 67.53 ± 8.68 years and 65.11 ± 9.72 years, respectively. The mean prostatic volume in the case group was significantly larger (71.1406 ± 3.32 cm3) than the control group (17.30 ± 4.72 cm3). The study found a significant association between androgenic alopecia and BPH (p <0.05), with an odds ratio of 4.56. Additionally, androgenic alopecia and arterial hypertension were identified as factors related to BPH. The study concluded that androgenic alopecia could be an early marker of BPH.

View this study on journal.upao.edu.pe →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Male pattern baldness, and mental health

in Finasteride/Dutasteride 323 upvotes 8 months ago

A 48-year-old man has been using minoxidil for 15 years and considered finasteride but stopped due to potential side effects. He is concerned about his mental health and the impact of hair loss on self-image, and he encourages support among men experiencing hair loss.

community Hair Loss Drugs Ranked in Order of Efficacy

in Research/Science 67 upvotes 10 months ago

Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

community My mum is mad annoying about Fin.

in Chat 245 upvotes 4 months ago

A 25-year-old man discusses his struggles with his mother's opposition to his use of Finasteride for hair loss treatment, despite it improving his condition and self-control after a hair transplant. He expresses frustration over her blaming the medication for various issues and the stress caused by her insistence to stop taking it.

community Topical Finasteride Doesn't Directly Reduce 5ar Enzyme on Scalp

in Finasteride/Dutasteride 72 upvotes 1 year ago

Topical Finasteride doesn't directly reduce 5ar enzyme on scalp and has the same mechanism as oral, needing to go through the liver. Users debate the accuracy of this information and discuss various studies and experiences.

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 1 month ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases

in Research/Science 34 upvotes 5 months ago

Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.

Similar Research

6 / 1000+ results

Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer

research Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer

11 citations, April 2013 in “Journal of Agricultural and Food Chemistry”

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

research The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

218 citations, January 2012 in “Advances in Urology”

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

research Association of Benign Prostatic Hyperplasia with Male Pattern Baldness

54 citations, May 1998 in “Urology”

Men with enlarged prostates often have more severe baldness.

research The Association of Male Pattern Baldness in Men with Benign Prostatic Hyperplasia

April 2023 in “Jordan Medical Journal”

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

research Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials

57 citations, July 2016 in “The Journal of Sexual Medicine”

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

research Benign Prostatic Hyperplasia, Metabolic Syndrome, and Androgenic Alopecia: Is There a Possible Relationship?

7 citations, February 2016 in “Arab journal of urology”

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.